Legislative Efforts

Administrative Rule

Rulemaking proceedings begin with a scope statement that is published in the Administrative Register.

The scope statements listed below are from the current legislative session. If you would like to view scope statements published prior to this session you can visit the legislative website here.

You may search for this information by agency, keyword, or by register date on which the rule was first introduced.

Register
Number:
548
(August
15,
2001)

Controlled Substances Board - Delete gamma-butyrolactone (GBL) from s. 961.14 (5) (ag), Stats.

Relating To: Delete gamma-butyrolactone (GBL) from s. 961.14 (5) (ag), Stats.
Register Number: 548 (August 15, 2001)
Clearinghouse Rule: CR 01-107
Add to a FOCUS Subscription

Lobbying Principals

Print
Principal Name Notified Date Communication Date Comments Supporting Documentation  
Orphan Medical Notified Date 3/4/2002 Communication Date N/A Comments   Supporting Documentation  
Other
Report Date
3/4/2002

Comments
Attended controlled substances board meeting to answer questions about the descheduling of GBL and advocate for controlling 1,4 BD as well as discuss ways to allow FDA approved medical GHB for narcolepsy patients
Pharmacy Society of Wisconsin Notified Date 8/19/2003 Communication Date N/A Comments   Supporting Documentation  
None
Report Date
8/19/2003

Lobbying Efforts

No principal has reported any activity on this administrative rule during the current legislative session.